Goslinski et al.
over 1 h, and the mixture was stirred at ambient temperature for 4
h. Pyridine was removed by distillation to leave a crude residue
containing 5a, which was further washed with hexanes (40 mL)
and chromatographed (CH2Cl2/MeOH 50:1) to give porphyrazine
9: Rf 0.47 (MeOH/CH2Cl2 1:50). MS(FAB+): m/z 745 (M+•).
HRMS (FAB+) Calcd for C37H49N10O3Zn: (M + H)+ 745.3281.
Found: (M + H)+ 745.3288. MeO2CCOCl (2 × 150 µL, 1.6 mmol)
was added, with stirring, in two portions to porphyrazine 9 in
pyridine (15 mL) over 1 h. The mixture was stirred at ambient
temperature overnight. MeOH (1 mL) was added, and the mixture
was stirred for a further 30 min. Rotary evaporation gave a residue,
which was washed with hexanes (20 mL) and chromatographed
(CH2Cl2/MeOH 50:1, CH2Cl2/MeOH/Et3N 50:1:0.1) to give por-
phyrazine 13 (38 mg, 29%) as blue solid: Rf ) 0.28 (MeOH/
CH2Cl2 1:50), Rf ) 0.50 (EtOAc/hexanes 1:1). IR (film): 3216,
1727, 1682, 1532, 1463, 1306, 1152, 1013 cm-1. UV-vis
(CH2Cl2): λmax (log ꢀ) 346 (4.77), 596 (4.64), 612 (4.73), 649 (4.04)
) 1.276 g cm-3; µ(Cu KR) ) 0.449 mm-1; T ) 173(2) K; deep
red blocks; 33 011 reflections collected; F2 refinement; R1 ) 0.0823,
R2 ) 0.1905; 19 487 observed reflections [|Fo| > 4σ(|Fo|), 2θ )
65.38°]; 808 parameters. Porphyrazine 15a showed the following
data: Rf ) 0.92 (MeOH/CH2Cl2 1:25). IR (film): 3287, 1691, 1524,
1146, 770 cm-1. UV-vis (CH2Cl2/MeOH 25:1): λmax (log ꢀ) 241
(4.78), 345 (4.75), 573 (4.51), 631 (4.65) nm. 1H NMR (400 MHz,
d5-pyridine/CDCl3 1:1): δ 13.01 (s, 2H), 8.88 (d, J ) 8.4 Hz, 2H,
overlapped with pyridine), 8.77 (d, J ) 8.4 Hz, 2H), 8.57 (m, 2H),
8.17 (d, J ) 7.5 Hz, 2H, overlapped with pyridine), 7.92 (d, J )
7.0 Hz, 2H), 4.37, 4.30, 4.14 (3t, J ) 8 Hz, 12H), 2.78, 2.67 (2 m,
12H), 1.51-1.68, (m, 18H). MS (FAB): m/z 907 (M + H)+. HRMS
(FAB) Calcd for C54H59N12O2: (M + H)+ 907.4884. Found: (M
+ H)+ 907.4863.
[7,8,12,13,17,18-Hexa-(4-tert-butylphenyl)-2,3-di-(quinoline-
2-carboxamido)porphyrazinato]zinc(II) (14b). H2S was bubbled
through porphyrazine 3b (36 mg, 0.028 mmol) in anhydrous
pyridine (8 mL) for 2 min. 2-Quinolinecarbonyl chloride (54 mg,
0.28 mmol) suspended in PhMe (2 mL) was added, and the mixture
was stirred at ambient temperature for 4 h. MeOH (3 mL) was
added to the solution containing crude 5b, and the resulting mixture
was stirred for 30 min. Pyridine was removed by distillation to
leave a crude residue, which was washed with hexanes and
chromatographed (CH2Cl2/MeOH 10:1) to give porphyrazine 10b.
MS (FAB): m/z 1355 (M+•). MS (MALDI): m/z 1355.5 (M+•).
Porphyrazine 10b and 2-quinolinecarbonyl chloride (54 mg, 0.28
mmol) in pyridine (8 mL) were stirred for 18 h at ambient
temperature. The pyridine was removed by distillation, and the
residue washed with hexanes (50 mL) and chromatographed
(CH2Cl2/MeOH 25:1 and 50:1) to give porphyrazine 15b (18 mg,
44%) as a violet product and porphyrazine 14b (14 mg, 34%) as a
green product. Porphyrazine 14b showed the following data: mp
> 300 °C (CHCl3/EtOH/ClCH2CH2Cl/iPrOH), Rf ) 0.78 (MeOH/
CH2Cl2 1:50). IR (film): 3443, 1716, 1604, 1501, 1372, 1267, 1107,
978, 839, 769 cm-1. UV-vis (CH2Cl2/MeOH 50:1): λmax (log ꢀ)
1
nm. H NMR (500 MHz, d5-pyridine): δ 9.74 (br s, 2H), 4.00-
4.09 (m, 12H), 3.90 (s, 6H), 2.46-2.55 (m, 12H), 1.29-1.41, (m,
18H). 13C NMR (125 MHz, d5-pyridine): δ 162.0, 160.0, 159.8,
158.9, 154.6, 150.4, 145.0, 144.7, 144.6, 127.0, 53.5, 30.0, 28.6,
26.0, 15.1, 15.03, 14.99. MS (FAB): m/z 831 (M + H)+. HRMS
(FAB) Calcd for C40H51N10O6Zn: (M + H)+ 831.3284. Found: (M
+ H)+ 831.3319.
[7,8,12,13,17,18-Hexapropyl-2,3-di-(quinoline-2-carboxami-
do)porphyrazinato]zinc(II) (14a). H2S was bubbled through
porphyrazine 3a (121 mg, 0.165 mmol) in anhydrous pyridine (20
mL) for 150 s, during which time the blue color intensified.
2-Quinolinecarbonyl chloride (316 mg, 1.65 mmol) suspended in
PhMe (5 mL) was added, and the mixture was stirred at ambient
temperature for 4 h, during which time the color changed from
blue to blue-green. MeOH (1 mL) was added, and stirring was
continued for 30 min. Pyridine was removed by distillation, and
the residue was chromatographed (CH2Cl2/MeOH 10:1) to give
porphyrazine 10a: Rf 0.87 (MeOH/CH2Cl2 1:25). MS (FAB+): m/z
814 (M + H)+. HRMS (FAB+) Calcd for C44H52N11OZn: (M +
H)+ 814.3648. Found: (M + H)+ 814.3627. Porphyrazine 10a and
2-quinolinecarbonyl chloride (316 mg, 1.65 mmol) in pyridine (20
mL) were stirred for 18 h at ambient temperature. MeOH (1 mL)
was added to the mixture, and stirring was continued for 30
min. Pyridine was removed by distillation to leave a crude resi-
due, which was washed with hexanes (50 mL) and chromato-
graphed (CH2Cl2/MeOH 50:1) to give porphyrazine 15a (8 mg,
5%) as a violet solid and porphyrazine 14a (69 mg, 43%) as a
green product. Porphyrazine 14a showed the following data: mp
> 300 °C (pyridine/CH2Cl2/MeOH), Rf ) 0.61 (MeOH/CH2Cl2
1:25). IR (film): 3387, 1716, 1682, 1147, 1032, 769 cm-1. UV-
vis (CH2Cl2/MeOH 25:1): λmax (log ꢀ) 239 (3.81), 350 (4.66), 616
(4.54) nm. 1H NMR (400 MHz, d5-pyridine): δ 13.12 (s, 2H), 8.75
(d, J ) 8.4 Hz, 2H), 8.68 (d, J ) 8.7 Hz, 2H, overlapping with
solvent pyridine), 8.37 (d, J ) 8.4 Hz, 2H), 8.00 (t, J ) 8.1 Hz,
2H), 7.93 (d, J ) 8.1 Hz, 2H), 7.85 (d, J ) 7.8 Hz, 2H), 7.68 (t,
J ) 7.9 Hz, 2H), 4.18, 4.10 (t, J ) 7.5 Hz, t J ) 7.3 Hz, 12H),
2.69, 2.67 (2m, 12H), 1.48, 1.42-1.35, 1.26 (t, 2m, J ) 7.2 Hz,
18H). 13C NMR (100 MHz, d5-pyridine): δ 162.5, 159.2, 159.1,
152.2, 151.2, 150.8, 147.0, 144.7, 144.6, 144.3, 138.3, 137.8,
131.0, 130.4, 130.0, 129.9, 129.6, 128.7, 128.5, 128.3, 126.9,
119.5, 119.4, 30.0, 29.7, 28.9, 28.7, 26.2, 26.1, 24.5, 15.4, 15.1,
15.0. MS (FAB): m/z 969 (M + H)+. HRMS (FAB) Calcd for
C54H57N12O2Zn: (M + H)+ 969.4019. Found: (M + H)+ 969.4040.
Crystal data: C59H61N13O2Zn‚2C5H5N; M ) 1207.78; triclinic; P1h;
a ) 12.1703(5), b ) 15.7922(7), c ) 17.5468(7) Å; R ) 90.108-
(3), â ) 90.338(3), γ ) 111.202(4)°; V ) 3144.1(2) Å3; Z ) 2; Dc
1
374 (4.82), 641 (4.85) nm. H NMR (400 MHz, d5-pyridine): δ
12.73 (s, 2H), 8.85 (d, J ) 8.3 Hz, 2H), 8.68 (overlapping solvent
pyridine), 8.42 (d, J ) 8.4 Hz, 2H), 8.02 (m, 2H), 7.78 (m, 2H),
7.70 (d, J ) 8.4 Hz, 2H), 7.38 (m, 2H), 1.48, 1.47, 1.20 (3s, 54H).
MS (FAB): m/z 1511 (M+•). MS (MALDI): m/z 1512.0 (M +
H)+. Crystal data: [C101H97N13O2Zn]0.85‚[C96H92N12O2Zn]0.15‚
[C5H5N]0.25‚[C3H8O]0.25; M ) 1613.22; triclinic; P1h; a )
14.4592(19), b ) 18.004(4), c ) 19.772(2) Å; R ) 97.654(16), â
) 100.365(10), γ ) 112.803(14)°; V ) 4549.1(12) Å3; Z ) 2; Dc
) 1.178 g cm-3; κ(Cu KR) ) 0.813 mm-1; T ) 173(2) K; 41 945
reflections collected; F2 refinement; R1 ) 0.1486, R2 ) 0.3432;
8763 observed reflections [|Fo| > 4σ (|Fo|), 2θ ) 142.36°]; 1181
parameters. Porphyrazine 15b showed the following data: Rf )
0.94 (MeOH/CH2Cl2 1:50). IR (film): 3286, 1684, 1516, 1487,
1267, 1108, 953 cm-1. UV-vis (CH2Cl2): λmax (log ꢀ) 367 (4.88),
1
468 (4.44), 599 (4.64), 677 (4.90) nm. H NMR (400 MHz, d5-
pyridine): δ 12.72 (s, 2H), 8.45, 8.03, 7.79 (3 br s, 12H, overlapping
solvent pyridine), 1.49, 1.27, 0.85 (3 s, 54H). MS (FAB): m/z 1448
(M+•). MS (MALDI): m/z 1449.3 (M + H)+.
N′,N′,N′′,N′′-Dicopper(II) Di-([7,8,12,13,17,18-hexapropyl-2,3-
di-(quinoline-2-carboxamido)porphyrazinato])zinc (II) (18a).
1,8-Diazabicyclo[5.4.0]undec-7-ene (DBU) (11 µL, 0.074 mmol)
in DMF (1 mL) was added to porphyrazine 14a (33 mg, 0.034
mmol) in DMF (5 mL). After 10 min, CuCl2 (9.9 mg, 0.074
mmol) in DMF (1 mL) was added, and the mixture was stirred for
24 h at ambient temperature. Rotary evaporation and chromatog-
raphy (CH2Cl2/MeOH 10:1) gave complex 18a (13 mg, 37%):
mp > 300 °C (HOCH2CH2OH/ClCH2CH2Cl/EtOH), Rf ) 0.28
3688 Inorganic Chemistry, Vol. 45, No. 9, 2006